NK

Naresh Kumar Goyal

Active Director Director DIN 00135922
DIN 00135922 First appointment Apr 1990 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 5 active board seats
Past companies 11 historical roles
Total affiliations 16 Since Apr 1990
Shareholding value β€’β€’β€’β€’ Premium profile
Directorship timeline
First appointment 09 Apr 1990
Active appointments 6
Total timeline records 16

Naresh Kumar Goyal (DIN 00135922) has 16 recorded board appointments in Indian companies, the first from April 1990, of which 6 are current. The chart and the list below show each company, the role held and the years of the appointment, as filed with the Ministry of Corporate Affairs.

Appointment history

Since 1990
Real Drugs Private Limited Director · 2024 – present
Current
Intact Drugs And Pharmaceuticlas Pvt.Ltd Director · 2024 – present
Current
Ndl Pythian Council Director · 2023 – present
Current
Dj Biotech Private Limited Director · 2021 – present
Current
Maiden Gourmet India Private Limited Director · 2009 – present
Current
Cureclip Pharmaceuticals Limited Director · 2005 – present
Current
Mg Lifecare Llp Designated Partner · 2021 – 2024
Previous
Rx91 Web Private Limited Director · 2020 – 2024
Previous
Delicious Chocolates Private Limited Director · 2017 – 2018
Previous
Shehanshah Buildwell Private Limited Director · 2008 – 2018
Previous
Sterling Compliances Private Limited Director · 2008 – 2016
Previous
A R K Health Care Pvt Ltd Additional Director · 2008 – 2021
Previous
Prg Pharma Private Limited Director · 2007 – 2021
Previous
Previous
Santosh Agro Food Private Limited Director · 2000 – 2013
Previous
Maiden Distributors Limited Director · 1990 – 2013
Previous

Interactive timeline

Hover bars for tenure details
Loading chart...
Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available